Skip to navigation Skip to content

Zeposia

Share

About this Medication
  • Brand Name: Zeposia® (zeh-poe’-see-ah)
  • Chemical Name: ozanimod (oh-ZAN-i-mod)
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This is an oral medication in capsule form.

Description

Zeposia® is a sphingosine 1-phosphate receptor modulator, which is thought to act by retaining certain white blood cells (lymphocytes) in the lymph nodes, thereby preventing those cells from crossing the blood-brain barrier into the central nervous system (CNS). Preventing the entry of these cells into the CNS reduces inflammatory damage to nerve cells.

Zeposia was approved by the U.S. Food and Drug Administration (FDA) for treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Read the Society's news bulletin on the FDA approval of Zeposia here.

Click here to read the Zeposia Prescribing Information for healthcare professionals.

Click here to read the Zeposia Medication Guide for patients.
 

Support

ZEPOSIA 360 SUPPORT
1-833-937-6742
www.zeposia.com/support-program-for-patients/

Financial Assistance Program

ZEPOSIA 360 SUPPORT
1-833-937-6742
https://www.zeposia.com/copay/



Share


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.